Published in Invest Ophthalmol Vis Sci on March 01, 2000
Comparison of the modified Early Treatment Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for diabetic macular edema. Arch Ophthalmol (2007) 3.18
Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalities. Curr Eye Res (2008) 2.69
Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol (2005) 1.95
Physiology of vitreous surgery. Graefes Arch Clin Exp Ophthalmol (2008) 1.70
Clinical applications of the sustained-release dexamethasone implant for treatment of macular edema. Clin Ophthalmol (2011) 1.46
"Guidance of macular laser photocoagulation: is fluorescein angiography still needed?". Graefes Arch Clin Exp Ophthalmol (2010) 1.39
Association between integrity of foveal photoreceptor layer and visual acuity in branch retinal vein occlusion. Br J Ophthalmol (2007) 1.22
Retinal vein occlusion: pathophysiology and treatment options. Clin Ophthalmol (2010) 1.07
Pain and accuracy of focal laser treatment for diabetic macular edema using a retinal navigated laser (Navilas). Clin Ophthalmol (2012) 1.01
[Retinal vein occlusions]. Ophthalmologe (2003) 1.01
Pars plana vitrectomy and removal of the internal limiting membrane in the treatment of chronic macular oedema. Graefes Arch Clin Exp Ophthalmol (2004) 0.92
Reliability of vessel diameter measurements with a retinal oximeter. Graefes Arch Clin Exp Ophthalmol (2011) 0.90
Intravitreal bevacizumab alone versus combined with macular photocoagulation in diabetic macular edema. Korean J Ophthalmol (2011) 0.90
Recent developments in laser treatment of diabetic retinopathy. Middle East Afr J Ophthalmol (2015) 0.86
Retinal sensitivity after resolution of the macular edema associated with retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol (2011) 0.86
Pars plana vitrectomy and internal limiting membrane peeling for macular edema secondary to retinal vein occlusion. Clin Ophthalmol (2011) 0.82
Changes in foveal thickness after vitrectomy for macular edema with branch retinal vein occlusion and intravitreal vascular endothelial growth factor. Int Ophthalmol (2008) 0.81
New Diagnostic and Therapeutic Approaches for Preventing the Progression of Diabetic Retinopathy. J Diabetes Res (2015) 0.81
Intravitreal injection of bevacizumab combined with macular grid laser photocoagulation for macular edema in branch retinal vein occlusion. Jpn J Ophthalmol (2011) 0.80
Extrafoveal changes following intravitreal bevacizumab injections for macular edema secondary to branch retinal vein occlusion: an mfERG and OCT study. Doc Ophthalmol (2012) 0.78
[Navigated focal retinal laser therapy using the NAVILAS® system for diabetic macula edema]. Ophthalmologe (2012) 0.77
Imaging retinal pigment epithelial proliferation secondary to PASCAL photocoagulation in vivo by polarization-sensitive optical coherence tomography. Am J Ophthalmol (2013) 0.77
Lamellar macular hole formation in chronic cystoid macular edema associated with retinal vein occlusion. Jpn J Ophthalmol (2011) 0.77
Intravitreous bevacizumab in the treatment of macular edema from branch retinal vein occlusion and hemisphere retinal vein occlusion (an AOS thesis). Trans Am Ophthalmol Soc (2008) 0.76
Safety and Efficacy of Ranibizumab in Macular Edema following Retinal Vein Occlusion. Ophthalmol Eye Dis (2012) 0.76
Optical coherence tomography parameters predictive of visual outcome after anti-VEGF therapy for retinal vein occlusion. Clin Ophthalmol (2016) 0.75
Evaluation of ultrasound-assisted thrombolysis using custom liposomes in a model of retinal vein occlusion. Invest Ophthalmol Vis Sci (2012) 0.75
New Developments in the Classification, Pathogenesis, Risk Factors, Natural History, and Treatment of Branch Retinal Vein Occlusion. J Ophthalmol (2017) 0.75
Evaluation of hyperreflective foci as a prognostic factor of visual outcome in retinal vein occlusion. Int J Ophthalmol (2017) 0.75
Changes of retinal flow volume after intravitreal injection of bevacizumab in branch retinal vein occlusion with macular edema: a case series. BMC Ophthalmol (2016) 0.75
Clinical Trials in Branch Retinal Vein Occlusion. Middle East Afr J Ophthalmol (2016) 0.75
Correlation between vascular endothelial growth factor and nonperfused areas in macular edema secondary to branch retinal vein occlusion. Clin Ophthalmol (2013) 0.75
[Navigated retinal laser therapy]. Ophthalmologe (2013) 0.75
The optics of vitreous surgery. Am J Ophthalmol (1981) 2.67
Individual risk assessment and information technology to optimise screening frequency for diabetic retinopathy. Diabetologia (2011) 1.44
Pseudoexfoliation syndrome in Icelandic families. Br J Ophthalmol (2001) 1.42
Biennial eye screening in patients with diabetes without retinopathy: 10-year experience. Br J Ophthalmol (2007) 1.34
Cyclodextrins as permeation enhancers: some theoretical evaluations and in vitro testing. J Control Release (1999) 1.27
Retinal vasoconstriction after laser treatment for diabetic macular edema. Am J Ophthalmol (1993) 1.15
"With the rule" astigmatism is not the rule in the elderly. Reykjavik Eye Study: a population based study of refraction and visual acuity in citizens of Reykjavik 50 years and older. Iceland-Japan Co-Working Study Groups. Acta Ophthalmol Scand (2000) 1.01
Retinal blood flow in normal and diabetic dogs. Invest Ophthalmol Vis Sci (1987) 1.00
Cyclodextrin solubilization of benzodiazepines: formulation of midazolam nasal spray. Int J Pharm (2001) 0.97
Panretinal photocoagulation and retinal oxygenation in normal and diabetic cats. Am J Ophthalmol (1986) 0.95
Screening for eye disease in type 2 diabetes mellitus. Acta Ophthalmol (Copenh) (1994) 0.95
Screening for diabetic retinopathy. Initiation and frequency. Acta Ophthalmol Scand (1995) 0.94
Optic nerve oxygen tension: effects of intraocular pressure and dorzolamide. Br J Ophthalmol (2000) 0.93
Central retinal artery occlusion during cardiac catheterization. Am J Ophthalmol (1985) 0.92
Retinal vessel dilatation and elongation precedes diabetic macular oedema. Br J Ophthalmol (1997) 0.92
Systematic screening for diabetic eye disease in insulin dependent diabetes. Acta Ophthalmol (Copenh) (1994) 0.91
Dorzolamide-timolol combination and retinal vessel oxygen saturation in patients with glaucoma or ocular hypertension. Br J Ophthalmol (2009) 0.91
Active prevention in diabetic eye disease. A 4-year follow-up. Acta Ophthalmol Scand (1997) 0.91
Age related macular degeneration in monozygotic twins and their spouses in Iceland. Acta Ophthalmol Scand (1999) 0.88
Topical drug delivery to the posterior segment of the eye: anatomical and physiological considerations. Pharmazie (2008) 0.87
Effects of retrobulbar bupivacaine on post-operative pain and nausea in retinal detachment surgery. Acta Ophthalmol (Copenh) (1993) 0.86
Quantitative measurements of retinal edema by specific gravity determinations. Invest Ophthalmol Vis Sci (1987) 0.86
In vivo O2 consumption in rhesus monkeys in light and dark. Exp Eye Res (1983) 0.85
Dexamethasone-cyclodextrin-polymer co-complexes in aqueous eye drops. Aqueous humor pharmacokinetics in humans. Invest Ophthalmol Vis Sci (1996) 0.85
Optic disk neovascularization and retinal vessel diameter in diabetic retinopathy. Am J Ophthalmol (1988) 0.84
Topically effective ocular hypotensive acetazolamide and ethoxyzolamide formulations in rabbits. J Pharm Pharmacol (1994) 0.80
Intraocular pressure effects on optic nerve-head oxidative metabolism measured in vivo. Graefes Arch Clin Exp Ophthalmol (1990) 0.77
Methazolamide 1% in cyclodextrin solution lowers IOP in human ocular hypertension. Invest Ophthalmol Vis Sci (2000) 0.77
Optic nerve oxygen tension: the effects of timolol and dorzolamide. Br J Ophthalmol (2004) 0.77
Prevention of diabetic blindness. Br J Ophthalmol (2006) 0.76
Indomethacin lowers optic nerve oxygen tension and reduces the effect of carbonic anhydrase inhibition and carbon dioxide breathing. Br J Ophthalmol (2004) 0.75
Diabetic maculopathy. Acta Ophthalmol Scand (1999) 0.75
Indomethacin decreases optic nerve oxygen tension by a mechanism other than cyclo-oxygenase inhibition. Br J Ophthalmol (2007) 0.75
Diacyl glyceryl ester prodrugs for slow release in the skin: synthesis and in vitro degradation and absorption studies for naproxen derivatives. Pharmazie (1999) 0.75
Capillary endothelial-cell mitogenic activity in experimental branch vein occlusion. Graefes Arch Clin Exp Ophthalmol (1990) 0.75
Exudative retinal detachment in familial pulmonary hypertension. Acta Ophthalmol (Copenh) (1991) 0.75
Biconcave contact lens for examination and laser treatment of the fundus in normal and gas-filled phakic eyes. Am J Ophthalmol (1984) 0.75